Drugs / DIMDAZENIL
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00401284 | Nov 2006 → Jul 2007 | sleep disorder, initiating and maintaining sleep | Evotec Neurosciences GmbH | Completed | No outcome recorded |
| Phase 2 | NCT00380003 | Sep 2006 → Apr 2007 | sleep disorder, initiating and maintaining sleep | Evotec Neurosciences GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DIMDAZENIL | ChEMBL registry synonym — accepted as the source's own label CHEMBL5095096 ↗ |
| Known as | EVT 201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00401284 ↗ |
| Modality | Small molecule | — CHEMBL5095096 ↗ |